Client Integration Enablement Specialist… at Grailbio · Remote

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL is headquartered in the bay area of California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com GRAIL is seeking a Client Integration Enablement Specialist to drive successful onboarding and activation of client integrations across a rapidly expanding portfolio of partners and integration pathways. This role sits at the intersection of clinical workflows, healthcare technology, and client engagement, serving as a strategic partner to health systems, digital health companies, and provider organizations. The individual will lead client-facing integration efforts, ensuring seamless adoption of Galleri ordering and results workflows across multiple platforms, including Epic (Aura), Athena, Quest, point-to-point HL7 integrations, and other lab platforms. This role is highly cross-functional and requires the ability to translate between clinical, technical IT, and operational stakeholders to enable scalable, high-quality integrations. Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL is headquartered in the bay area of California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com